About Ampersand Biomedicines
Ampersand is enabling potent mechanisms to treat disease by creating and programming therapeutics that are more efficacious, without compromising on safety or tolerability.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-B
Global Headquarters
Boston, United States
Year Founded
2021
Team Size
11–50 employees
Tracked Since
Nov 8, 2026
Web & Domain Identity
Official Website
ampersand.bio
Domain Registered Date
Undisclosed
Social & Network Presence
X / Twitter Profile
@AmpersandBio
(117 followers)
LinkedIn Corporate
Company Profile
Company Milestones & Timeline
- Capital Raise
Raised $65,000,000 · Series-B
fundraisingfox.com
- Milestone
Company founded
Boston, United States
Investors & Backers
Eli Lilly
Flagship Pioneering
Funding History
Series-B equity
· Mar 19, 2025
$65,000,000 fundraisingfox.com
Founders & Leadership
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allTesorai
tesorai.com
Seed Nov 2026
Commit Biologics
commitbio.com
Seed Aarhus · Nov 2026
Human Biome
human-biome.com
Series-A Warsaw · Nov 2026
MedInTech
medintech.co.kr
Series-B Seoul · Nov 2026
Ace Padel
acepadel.com
Seed Bradenton, United States · Nov 2026
Mentix
mentix.world
Pre-Seed London, United Kingdom · Nov 2026